Lung involvement in patients with rheumatoid artritis

S. Borekci (Istanbul, Turkey)

Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Session: Best clinical practice for the management of chronic lung diseases
Session type: Poster Discussion
Number: 359
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Borekci (Istanbul, Turkey). Lung involvement in patients with rheumatoid artritis. 359

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary involvement in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 381s
Year: 2006

Interstitial lung disease in patients with rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Pulmonary manifestations in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006

Pulmonary involvement in rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Pulmonary involvement in rheumatoid arthritis
Source: Eur Respir Monogr 2019; 86: 44-67
Year: 2019


Pulmonary involvement in spondilarthropathies and rheumatoid polyarthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

Pulmonary nodular lesions in rheumatoid arthritis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Rituximab improves interstitial lung disease in rheumatoid arthritis patients
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Cavitary nodules in rheumatoid arthritis patients and their prognosis
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018


Pulmonary abnormalities in newly diagnosed rheumatoid arthritis
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 587s
Year: 2002

Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients
Source: Eur Respir J 2014; 44: 1082-1085
Year: 2014


Pulmonary disease associated with rheumatoid arthritis
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021

Late Breaking Abstract - Study of natural autoantibodies in rheumatoid arthritis patients with pulmonary involvement
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017



Rheumatoid arthritis-associated lung disease
Source: Eur Respir Rev 2015; 24: 1-16
Year: 2015


Involving lung in rheumatoid arthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Rheumatoid arthritis-related lung disease
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Methotrexate and rheumatoid arthritis associated interstitial lung disease
Source: Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020
Year: 2021



Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019